|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
|
|---|---|---|---|
| Revenues | |||
| Cost of revenues | |||
| Gross profit | |||
| Operating expenses: | |||
| General and administrative expenses | |||
| Selling and marketing expenses | |||
| Research and development expenses | |||
| Impairment loss on non-current assets | |||
| Total operating expenses | |||
| (Loss) income from operations | |||
| Other income (loss): | |||
| Interest expense | |||
| Interest income | |||
| Issuance costs allocated to warrant liability | |||
| Change in fair value of warrant liability | |||
| Other income (expense) | |||
| Total other income (loss), net | |||
| (Loss) income before income taxes | |||
| Income tax expense | |||
| Net (loss) income | |||
| Foreign currency translation gain (loss) | |||
| Total Comprehensive income | |||
| Foreign currency translation gain (loss) | |||
| Total comprehensive (loss) income | |||
| (Loss) earnings per ordinary share | |||
| Earnings (loss) earnings per share - basic | |||
| Earnings (loss) earnings per share - diluted | |||
| Denominator: | |||
| Weighted average shares outstanding - basic | |||
| Diluted (in Shares) |
Loading...